-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
Former executive vice president of R&D, Amgen.
-
Lecturer, Boston University School of Management
-
Managing Director, Enterprise Partners
-
Professor, Gene Expression Laboratory, Salk Institute
-
Meet All the Xconomists ›
-
Partner, Latham and Watkins
-
Professor, Biochemistry and Biophysics, UCSF
-
Consultant, MJTurner Consulting
-
HP Senior Fellow, Hewlett-Packard Laboratories
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO
|
Arlene Weintraub |
05/15/12 |
Boston
|
|
Radius Health Seeks $86M IPO
|
Arlene Weintraub |
02/07/12 |
Boston
|
|
PathoGenetiX Secures $7,500,000 Series B Financing
|
VentureDeal |
11/01/11 |
Boston
|
|
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News
|
Erin Kutz |
10/14/11 |
Boston
|
|
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial
|
Luke Timmerman |
10/07/11 |
Boston
|
|
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News
|
Erin Kutz |
09/16/11 |
Boston
|
|
PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News
|
Erin Kutz |
09/14/11 |
Boston
|
|
Tensha Therapeutics Receives $15,000,000 Series A Financing Round
|
VentureDeal |
09/13/11 |
Boston
|
|
Theraclone Snaps Up $10.6M Financing
|
Luke Timmerman |
09/08/11 |
Seattle
|
|
Theraclone Sciences Secures $10,600,000 Series B Round
|
VentureDeal |
09/08/11 |
Seattle
|
|
Cleveland Heartlab Lands $18,400,000 Series B Financing Round
|
VentureDeal |
08/22/11 |
Detroit
|
|
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs
|
Luke Timmerman |
05/25/11 |
Boston
|
|
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing
|
Arlene Weintraub |
05/24/11 |
Boston
|
|
Radius Health Obtains $91,000,000 New Funding
|
VentureDeal |
05/24/11 |
Boston
|
|
Proteostasis Adds Targets, Drugs From Harvard
|
Luke Timmerman |
04/26/11 |
Boston
|
|
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study
|
Ryan McBride |
03/11/11 |
Boston
|
|
EnerNOC Acquires M2M, H3 Launches With Eisai Funding, Genzyme Talks With Sanofi Advance, & More Boston-Area Deals News
|
Erin Kutz |
02/02/11 |
Boston
|
|
CloudTP Comes Out of Stealth, With $1M in Equity Seed Funding, to Help Big Companies Move Data to Their Own Private Clouds
|
Erin Kutz |
01/31/11 |
Boston
|
|
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More
|
Gregory T. Huang |
01/24/11 |
Boston
|
|
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections
|
Luke Timmerman |
01/18/11 |
Seattle
|
|
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News
|
Erin Kutz |
01/14/11 |
Boston
|
|
$10M for Dekkun
|
Erin Kutz |
01/10/11 |
Boston
|
|
Dekkun Receives $9,930,400 New Funding Round
|
VentureDeal |
01/10/11 |
Boston
|
|
Gilead Buys Arresto for $225M
|
Luke Timmerman |
12/20/10 |
San Francisco
|
|
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/01/10 |
Boston
|
|
Biotech DecImmune Grabs $1M from Astellas VC
|
Ryan McBride |
09/27/10 |
Boston
|
|
DecImmune Therapeutics Lands $1,000,000 New Funding Round
|
VentureDeal |
09/27/10 |
Boston
|
|
Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J
|
Ryan McBride |
09/09/10 |
Boston
|
|
VMware Makes Two Acquisitions, Mascoma Picks Up SunOpta Unit, Vela Gets $6M, & More Boston-Area Deals News
|
Erin Kutz |
09/08/10 |
Boston
|
|
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area
|
Ryan McBride |
09/01/10 |
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.